ArticleThe Australian and New Zealand journal of psychiatry2026
Examining the effectiveness of the Better Access initiative using data from real-world practice settings.
Article in The Australian and New Zealand journal of psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Uptake, utilisation and costs of treatment through Better Access from 2018 to 2022: An analysis of Medicare Benefits Schedule data.The Australian and New Zealand journal of psychiatry · 2026Article
- Examining Better Access use by Australian adults using data from two longitudinal studies (Ten to Men and the Australian Longitudinal Study on Women's Health).The Australian and New Zealand journal of psychiatry · 2026Observational
- Who uses Better Access treatment services? A re-analysis of data from the usual care arms of two randomised controlled trials.The Australian and New Zealand journal of psychiatry · 2026Article
- Accessibility and responsiveness of Better Access treatment services: Insights from the use of linked administrative data in the evaluation of Better Access.The Australian and New Zealand journal of psychiatry · 2026Article
- Evaluation of Australia's Better Access initiative: An overview.The Australian and New Zealand journal of psychiatry · 2026Review
- Australia's Better Access initiative: A survey of provider and referrer views.The Australian and New Zealand journal of psychiatry · 2026Article
- A virtual consultative forum on future reforms to Better Access.The Australian and New Zealand journal of psychiatry · 2026Article
- Consumers' experiences with and outcomes from Better Access: Results from a national survey.The Australian and New Zealand journal of psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
objectiveThis study examined the effectiveness of the Better Access initiative using outcome data from real-world practice settings.
methodsWe used anonymised data from four datasets to assess outcomes for consumers over 86,121 episodes of care. The datasets contained routinely captured episode-level data from the practices of psychologists and other eligible Better Access providers. Across the datasets, outcomes were assessed on 11 different measures (mostly consumer-rated measures of depression and anxiety symptoms, psychological distress, functioning and wellbeing). We conducted purpose-designed analyses with three of the datasets (83,346 episodes), examining score changes on given measures between the first and last assessment occasion within an episode. We used preexisting outputs for the fourth dataset (2775 episodes), again considering change from the beginning to the end of the episode.
resultsIn the purpose-designed analyses, consumers' mental health improved in around 50-60% of episodes. However, consumers showed no change or experienced deterioration in their mental health in 20-30% and 10-20% of episodes, respectively. Those with more severe baseline scores had a greater probability of showing improvement. The preexisting outputs also identified significant improvements, particularly in episodes where treatment was complete.
conclusionBetter Access is achieving reductions in symptoms and improvements in functioning and wellbeing for the majority of consumers. A minority of consumers do not have these sorts of positive outcomes, however, and further work is required to understand why. Routine measurement of outcomes - particularly consumer-rated outcomes - would enable ongoing monitoring of the extent to which Better Access is achieving its goals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.